Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at email@example.com if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to firstname.lastname@example.org so that we can defer those challenges. Your health and safety are paramount to us.
Posted 10 September 2014 | By Alexander Gaffney, RAC,
The US Food and Drug Administration (FDA) has announced the hire of a new senior official, Cynthia Schnedar, who will serve as the director of the Center for Drug Evaluation and Research's (CDER) Office of Compliance (OC), its drug compliance enforcement division.
The position had been vacated earlier this year by Howard Sklamberg, who had served as director of CDER's OC since November 2012. In January 2014, Sklamberg was promoted to the position of deputy commissioner for Global Regulatory Operations and Policy (GO), leaving the position without a permanent director.
Schnedar, the new hire, had most recently been a part of the Department of Justice, where she served as the deputy inspector general since 2010. Prior to that position, she served several other roles within DOJ, including acting inspector general and counselor to the inspector general. Schnedar also previously worked for more than a decade at the US Attorney's Office in DC, where she worked in the Sex Offense and Domestic Violence Section.
In an email to staff, CDER Director Janet Woodcock said she believed Schnedar would be "an asset to CDER and Office of Compliance leadership."
"Her expertise in law enforcement, and extensive experience as an attorney and leader in the federal government, enables her to bring a valuable mix of knowledge and ability to analyze complex statutory and regulatory issues."
Schnedar will step in for Carol Bennett, who has been serving as acting director of the Office of Compliance since Sklamberg's promotion. Bennett will return to the Office of Regulatory Policy, Woodcock said, and OC Deputy Director Ilisa Bernstein will serve as acting director until Schnedar is formally brought on board.
Tags: Office of Compliance, Cynthia Schnedar
Regulatory Focus newsletters
All the biggest regulatory news and happenings.